InsiderTrades.com logo
Protect Yourself While There’s Still Time …
From Weiss Ratings   |   Ad
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
4 simple steps to protect your privacy and money before it’s too late.
Eric I. Schwartz net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Eric Schwartz Biography and Net Worth

EVP of Integra LifeSciences

Prior joining Integra in 2018, Mr. Schwartz was the general counsel at Globus Medical, a global orthopedic medical devices company, where he led several strategic transactions, including the largest acquisition in its company history, and led a cross-functional team responsible for integrating operations in over 20 countries. Prior to that he was the COO and chief legal officer of CardioVIP, a technology-enabled clinical provider assisting physicians with comprehensive disease management for their patients with cardiovascular disease. Between 2004 to 2006, he was general counsel at Animas Corporation, where he played a key role in the sale of the company to Johnson & Johnson. Following that transaction, Eric assumed the role of assistant general counsel at Johnson & Johnson, serving on the management boards of McNeil Nutritionals and Ethicon Biosurgery.

Mr. Schwartz received his bachelor’s degree in English and juris doctorate degree from the University of Virginia. He also holds a master’s degree in business from the Wharton School of the University of Pennsylvania.

What is Eric I. Schwartz's net worth?

The estimated net worth of Eric I. Schwartz is at least $833,451.06 as of February 25th, 2021. Mr. Schwartz owns 29,409 shares of Integra LifeSciences stock worth more than $833,451 as of April 26th. This net worth estimate does not reflect any other assets that Mr. Schwartz may own. Additionally, Mr. Schwartz receives an annual salary of $549,520.00 as EVP at Integra LifeSciences. Learn More about Eric I. Schwartz's net worth.

How old is Eric I. Schwartz?

Mr. Schwartz is currently 55 years old. There are 7 older executives and no younger executives at Integra LifeSciences. The oldest executive at Integra LifeSciences is Mr. Robert T. Davis Jr., Executive VP & President of Tissue Technologies, who is 65 years old. Learn More on Eric I. Schwartz's age.

What is Eric I. Schwartz's salary?

As the EVP of Integra LifeSciences Holdings Co., Mr. Schwartz earns $549,520.00 per year. There are 3 executives that earn more than Mr. Schwartz. The highest earning executive at Integra LifeSciences is Mr. Jan De Witte, President, CEO & Director, who commands a salary of $888,670.00 per year. Learn More on Eric I. Schwartz's salary.

How do I contact Eric I. Schwartz?

The corporate mailing address for Mr. Schwartz and other Integra LifeSciences executives is 311 ENTERPRISE DRIVE, PLAINSBORO NJ, 08536. Integra LifeSciences can also be reached via phone at (609) 275-0500 and via email at [email protected]. Learn More on Eric I. Schwartz's contact information.

Has Eric I. Schwartz been buying or selling shares of Integra LifeSciences?

Eric I. Schwartz has not been actively trading shares of Integra LifeSciences during the past quarter. Most recently, Eric Schwartz sold 4,212 shares of the business's stock in a transaction on Tuesday, March 2nd. The shares were sold at an average price of $69.10, for a transaction totalling $291,049.20. Learn More on Eric I. Schwartz's trading history.

Who are Integra LifeSciences' active insiders?

Integra LifeSciences' insider roster includes Richard Caruso (Major Shareholder), Glenn Coleman (COO), Jan De Witte (CEO), Stuart Essig (Director), Lisa Evoli (EVP), Michael McBreen (EVP), Jeffrey Mosebrook (SVP), Raymond Murphy (Director), and Eric Schwartz (EVP). Learn More on Integra LifeSciences' active insiders.

Are insiders buying or selling shares of Integra LifeSciences?

In the last year, Integra LifeSciences insiders bought shares 1 times. They purchased a total of 7,792 shares worth more than $299,992.00. The most recent insider tranaction occured on June, 1st when CEO Witte Jan De bought 7,792 shares worth more than $299,992.00. Insiders at Integra LifeSciences own 3.1% of the company. Learn More about insider trades at Integra LifeSciences.

Information on this page was last updated on 6/1/2023.

Eric I. Schwartz Insider Trading History at Integra LifeSciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/2/2021Sell4,212$69.10$291,049.20
2/25/2021Sell2,288$69.52$159,061.7629,409View SEC Filing Icon  
12/5/2019Sell4,007$62.25$249,435.75
See Full Table

Eric I. Schwartz Buying and Selling Activity at Integra LifeSciences

This chart shows Eric Schwartz's buying and selling at Integra LifeSciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Integra LifeSciences Company Overview

Integra LifeSciences logo
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Read More

Today's Range

Now: $28.34
Low: $28.13
High: $28.81

50 Day Range

MA: $35.34
Low: $28.34
High: $45.20

2 Week Range

Now: $28.34
Low: $27.18
High: $56.21

Volume

446,577 shs

Average Volume

702,426 shs

Market Capitalization

$2.23 billion

P/E Ratio

34.14

Dividend Yield

N/A

Beta

1.12
Protect Yourself While There’s Still Time …
From Weiss Ratings   |   Ad
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
4 simple steps to protect your privacy and money before it’s too late.